中文名 | TDZD-8 |
英文名 | TDZD-8 |
别名 | 化合物TDZD8 4-苄基-2-甲基-1 TDZD-8,GSK-3Β抑制剂 4-苄基-2-甲基-1,2,4-噻二唑烷-3,5-二酮 4-苯甲基-2-甲基-1,2,4-噻二唑烷-3,5-二酮 |
英文别名 | TDZD8 TDZD 8 TDZD-8 NP 01139 GSK-3InhibitorI,TDZD-8 4-BENZYL-2-METHYL-1,2,4-THIADIAZOLIDINE-3,5-DIONE 2-Methyl-4-(phenylmethyl)-1,2,4-thiadiazolidine-3,5-dione 1,2,4-Thiadiazolidine-3,5-dione,2-Methyl-4-(phenylMethyl)- 4-Benzyl-2-methyl-[1,2,4]thiadiazolidine-3,5-dione TDZD-8 |
CAS | 327036-89-5 |
化学式 | C10H10N2O2S |
分子量 | 222.26 |
密度 | 1.375±0.06 g/cm3(Predicted) |
熔点 | 63-64.4°C |
沸点 | 335.5±35.0 °C(Predicted) |
溶解度 | DMSO: 18 mg/mL |
酸度系数 | -2.08±0.20(Predicted) |
存储条件 | 2-8°C |
外观 | 针头 |
颜色 | white |
MDL号 | MFCD04973552 |
体外研究 | TDZD-8作为非ATP竞争性抑制剂或与GS-1结合。在激酶实验中,TDZD-8对PKA, PKC, Cdk-1/cyclin B 和 CK-II 没有抑制效果。 TDZD-8特异性诱导原代白血病细胞样本发生细胞死亡。TDZD-8可以除去白血病祖细胞和干细胞。TDZD-8诱导细胞死亡,具有极其迅速的细胞死亡动力学,且细胞膜完全丧失。TDZD-8作用于原代AML细胞样本,抑制PKC和 FLT3。 |
体内研究 | TDZD-8 (TDZD8, 1 or 2 mg/kg, i.p.) both reduces the induction of p-DARPP32 following chronic L-dopa treatment in parkinsonian animals. TDZD8 treatment of 21 days induces a significant reduction in PKA expression in rats with established dyskinesia. Moreover, TDZD8 reduces FosB mRNA level in the striatum and lowers the expression of PPEB mRNA to similar levels as in 6-OHDA-lesioned rats without treated with L-dopa. The decrease in dyskinesia induced by TDZD8 is overcome by dopamine rceptor-1 agonist. |
危险品标志 | Xi - 刺激性物品 |
风险术语 | 43 - 与皮肤接触可能致敏。 |
安全术语 | 36/37 - 穿戴适当的防护服和手套。 |
WGK Germany | 3 |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 4.499 ml | 22.496 ml | 44.992 ml |
5 mM | 0.9 ml | 4.499 ml | 8.998 ml |
10 mM | 0.45 ml | 2.25 ml | 4.499 ml |
5 mM | 0.09 ml | 0.45 ml | 0.9 ml |
微信搜索化工百科或扫描下方二维码,添加化工百科小程序,随时随地查信息!